Business profile & competitive position
RTX Corporation operates in the Industrials sector under the Aerospace & Defense industry. It is not a single-theme company: the business is organized into three segments that together cover commercial aviation, military propulsion, and defense systems. Collins Aerospace supplies avionics, cabin interiors, environmental and power systems, and connected aviation solutions. Pratt & Whitney makes commercial and military aircraft engines, auxiliary power units, and aftermarket services. Raytheon designs integrated air and missile defense, smart weapons, sensors, radars, and space systems. Because these segments sit on both sides of the aerospace cycle—original equipment and long-tail aftermarket support—RTX’s revenue base is diversified across aircraft manufacturers, airlines, the U.S. government, foreign governments, and other defense contractors.
The company’s financial signature supports the idea of a durable but capital-intensive franchise. Net margin is 8.9% and return on equity is 12.8%. Those figures are healthy for a long-cycle defense and aerospace conglomerate, but they are not software-like. They imply a business that earns respectable returns while carrying heavy R&D, fixed-price contract risk, and regulatory compliance burdens. The more telling competitive signal is backlog. At December 31, 2025, total backlog reached $268 billion, up from $218 billion a year earlier. In 2025, U.S. government sales were $33.3 billion, or 38% of net sales, while international sales contributed $41.3 billion, or 47%. That backlog-heavy revenue mix gives RTX multi-year demand visibility and creates switching costs for customers who depend on certified aerospace systems and long-term spare-parts logistics.
Financial posture
As of the current snapshot, RTX carries a market capitalization of $264.9 billion and trades at a price-to-earnings ratio of 31.5. Against a net margin of 8.9% and an ROE of 12.8%, that P/E sits at a premium to many industrial peers. The valuation appears to reflect above-average confidence in the company’s backlog, execution track record, and exposure to both commercial aviation recovery and rearmament themes. A beta of 0.30 is unusually low by equity-market standards, suggesting the stock has historically moved far less than the overall market. That makes sense for a defense-heavy cash-flow business, though it also means much of RTX’s near-term narrative may already be embedded in the price.
Profitability is solid rather than spectacular. The 12.8% ROE indicates the company generates a reasonable return above its cost of equity, while the 8.9% net margin reflects the mix of higher-margin aftermarket services and lower-margin large-scale production programs. Investors should view these metrics as-contextual: in aerospace and defense, margins are often capped by contract type, government negotiation, and supplier inflation, so even small changes in working capital or program execution can shift the profile materially.
Strategic priorities & outlook
RTX’s most recent 10-K filing outlines a clear set of near-term operational priorities across each segment. Collins Aerospace is investing in sustainable aviation technologies, including advanced composite materials, hybrid-electric systems, and alternative energy research. It is also expanding operational capacity in the United States, Puerto Rico, India, Mexico, Singapore, and the Philippines. Pratt & Whitney is focused on enhancing engine programs through performance improvements and product base expansion, while maturing the F135 Engine Core Upgrade and advancing the XA103 engine for the U.S. Air Force’s Next Generation Adaptive Propulsion program. Pratt is also leading the PHARES hybrid-electric regional-aircraft propulsion demonstrator program with Collins and other consortium members to improve fuel efficiency.
On the defense side, Raytheon is prioritizing next-generation systems such as hypersonics, counter-hypersonics, next-generation radars, and electro-optical/infrared advancements. These programs align with the $268 billion backlog and the mix of U.S. and international demand. The filing also flags operational friction: RTX has experienced ongoing supply-chain disruptions, inflation-driven cost increases, and geopolitically related sourcing constraints, and is responding with second- and third-sourcing strategies plus higher inventory levels. In addition, the company remains under significant compliance obligations tied to two DOJ deferred prosecution agreements, an SEC administrative order, and a State Department consent agreement concerning past Middle East payments, defective pricing, and ITAR compliance. Those overhangs are part of the strategic landscape even when headline defense spending looks favorable.
Macro & geopolitical exposure
As an Aerospace & Defense company, RTX is exposed to the full policy and procurement cycle of U.S. and allied military budgets. Defense authorization bills, supplemental funding for Ukraine or other theaters, and foreign military sales approvals can all move the revenue needle over time. The company is also exposed to export-control regimes, including ITAR, which affect which systems can be sold to which countries and how intellectual property is handled. Currency is a factor too: with 47% of 2025 sales coming from international markets, dollar strength or weakness can influence reported results even when local-currency demand is stable.
Industry-level risks include commodity-price volatility in aerospace materials, semiconductor shortages in avionics and guidance systems, supplier bottlenecks, and labor-cost inflation. These are not abstract concerns for RTX: the 10-K explicitly cites supply-chain disruptions, inflation-driven cost increases, and geopolitically related sourcing constraints as live issues. Regulatory risk is similarly concrete, given the consent agreements and deferred prosecution agreements governing the company’s conduct. In short, RTX’s macro playbook is dominated by defense budgets, geopolitical alignment, production economics, and government compliance rather than by consumer demand or short-term cyclical spending.
Recent developments
A cluster of recent headlines shows both company-specific progress and sector-wide uncertainty. On November 9, 2026, PR Newswire reported that RTX’s Raytheon unit advanced its Joint Reduced Range Rocket program with a third successful flight test, reinforcing the next-generation weapons trajectory described in the 10-K. On November 6, 2026, Defenseworld.net noted that Chicago Partners Investment Group LLC grew its holdings in RTX. The same day, CNBC published a broader defense-sector piece titled “Tanks or drones? Defense earnings reveal a more complicated rearmament boom,” framing industry-wide demand in a more nuanced light than a simple capex surge. On November 5, 2026, 247wallst.com reported that defense stocks sank after Democrats took Congress and the $1.5 trillion budget looked doomed, a reminder that RTX’s stock price is not insulated from Washington’s legislative calendar.
Taken together, these headlines capture the tension in the stock right now: solid program execution and backlog on one side, and headline risk around U.S. fiscal politics and the shape of future military spending on the other.
Earnings behavior & post-earnings drift
RTX has put together an unusually consistent earnings record. Over the last eight reported quarters, the company beat consensus estimates every time, for a 100% beat rate, with an average earnings surprise of 14.2%. The most recent four quarters illustrate both the consistency and the market’s occasionally skeptical reaction to good news. On October 20, 2026, RTX reported actual EPS of $2.26 against an estimate of $1.78, a 27.0% positive surprise, yet the stock fell 0.9% the next day and rose only 0.65% over the following five days. On July 23, 2026, actual EPS was $1.89 versus $1.66 estimated, a 13.9% beat, with the stock gaining 1.74% the next day and 2.5% over five days. On April 21, 2026, actual EPS of $1.78 beat the $1.51 estimate by 17.9%, but the stock dropped 3.34% the next day and 6.14% over the following five days. On January 27, 2026, actual EPS of $1.55 beat the $1.47 estimate by 5.4%, with a next-day decline of 0.9% and a five-day gain of 1.1%.
The average five-day post-earnings move across the trailing eight quarters is negative 0.47%, classified as “flat” drift. This pattern suggests that while RTX reliably clears consensus, much of the operational strength is often already reflected in the share price by the time results are printed. The October 2026 quarter is the clearest example: a 27% EPS beat produced a same-session sell-off. In heavily covered defense names, the gap between published consensus and the market’s real expectation can be wide. RTX is next scheduled to report on January 26, 2027, before the open, with a current consensus EPS estimate of $1.82. As of the latest snapshot, the stock closed at $196.31, with an RSI of 52.4 and a 50-day EMA of $195.00, leaving it roughly in line with its short-term moving average heading into that event.
Frequently Asked Questions
What are RTX’s three main business segments?
RTX is split into Collins Aerospace (avionics, cabin interiors, environmental and power systems), Pratt & Whitney (commercial and military engines, auxiliary power units, and aftermarket services), and Raytheon (air and missile defense, smart weapons, sensors, radars, and space systems).
How reliable has RTX’s earnings performance been?
Over the last eight reported quarters, RTX beat consensus EPS estimates every time, for a 100% beat rate, with an average earnings surprise of 14.2%. Each of the four most recent quarters, ending with the October 20, 2026 report, also topped estimates.
How has RTX stock typically traded after earnings?
The average five-day post-earnings move across the trailing eight quarters is negative 0.47%, which is classified as flat. Individual reactions have varied: the July 2026 quarter saw a five-day gain of 2.5%, while the April 2026 quarter saw a five-day drop of 6.14%, showing that beating estimates has not always produced a higher stock price.
For a deeper dive into how professional analysts are weighing RTX’s backlog, valuation, and the upcoming January 26, 2027 earnings report, consider reviewing the full institutional verdict and consensus model rather than relying on any single headline or quarter.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-10-20 | $2.26 | $1.78 | +27% | -0.9% | +0.65% |
| 2026-07-23 | $1.89 | $1.66 | +13.9% | +1.74% | +2.5% |
| 2026-04-21 | $1.78 | $1.51 | +17.9% | -3.34% | -6.14% |
| 2026-01-27 | $1.55 | $1.47 | +5.4% | -0.9% | +1.1% |
| 2025-10-21 | $1.7 | $1.41 | +20.6% | - | - |
| 2025-07-22 | $1.56 | $1.44 | +8.3% | - | - |
Previous RTX editions
Get the institutional verdict on RTX
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the RTX verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.